The Biosimilars Council agrees with the FDA's position that data from a switching study or studies may no longer be necessary to support licensure of interchangeable biosimilar medicines.
Some 66% of shoppers held off making back-to-school buys until Amazon Prime Day, while 73% plan to capitalize on back-to-school deals during the Labor Day sales.